Avoiding pitfalls in peptide synthesis: Amine side reactions

In recent years, with breakthroughs in peptide drugs in areas such as metabolism, oncology, and anti-infection, the global peptide drug market has continued to heat up . Against this backdrop, the efficiency and quality control of peptide synthesis processes have become particularly critical. In peptide synthesis, the amino group is the most common nucleophile , and its acylation reaction is the fundamental principle of amino acid coupling and peptide chain elongation ; however, due to its high reactivity , it is prone to various unexpected side reactions during synthesis, which can seriously affect the purity and yield of the target product. Common side reactions include acetylation, trifluoroacetylation, formylation, and alkylation.

I. Side Reactions of Nα ^- acetylation and Trifluoroacetylation

1. ^Nα -acetylation of peptide chains :

^{Nα -acetylation} of peptide chains is a common side reaction in solid-phase peptide synthesis (SPPS), which can lead to the unintended termination of peptide chain assembly and the formation of truncated peptide impurities. Besides residual acetic acid in commercially available amino acid feedstocks potentially triggering acetylation side reactions, the artificial addition of acetic anhydride for end-capping can also unintentionally introduce impurities .

Nα during subsequent peptide chain elongation, undergoing an acetylation side reaction that terminates the ongoing peptide chain elongation. On the other hand, ^{if the protecting group} (such as the p-toluenesulfonyl group) on the histidine imidazole side chain is prematurely removed, acetic anhydride treatment may cause imidazole acetylation of the histidine side chain. The resulting acetimidazole intermediate will then lead to ^Nα -acetylation through a migration reaction , which will also terminate peptide chain growth.

In addition, the capping process may be accompanied by excessive acetylation side reactions, leading to the formation of N-acetylacetamide derivatives (Figure 1).

Figure 1. Nα ^{hyperacetylation} reaction

2. Trifluoroacetylation :

Trifluoroacetylation is a common side reaction in peptide synthesis, primarily stemming from the reaction of trifluoroacetic acid (TFA) with amino or hydroxyl groups. This reaction frequently occurs during peptide cleavage from resins, complete deprotection of side chains, and repeated deprotection steps in Boc solid-phase synthesis .

For example, when synthesizing peptides using the Boc solid-phase synthesis method, repeated removal of the Boc protecting group with trifluoroacetic acid may cause premature breakage of the ester bond between the peptide chain and the resin, forming a trifluoroacetate derivative. In a subsequent alkaline environment, O→N acyl migration occurs, forming short peptide impurities with trifluoroacetyl-terminated ends (Figure 2). Similarly, the above-mentioned O→N acyl migration process also occurs when processing amino acid residues containing hydroxyl groups, such as serine and threonine.

Figure 2. Trifluoroacetylation reaction initiated by O→N acyl group migration.

II. Formylation Side Reactions

Carbamylation is a common protein modification strategy. However, aberrant carbamylation originating from various processes has adversely affected peptide synthesis. The main causes of carbamylation side reactions are residual tryptophan side-chain protecting groups, the introduction of formic acid reagents, and degradation by DMF solvent .

1. Residual Protecting Group: In Boc solid-phase synthesis , tryptophan is often protected with a formyl group for side chain protection. In peptide chains containing lysine, if deprotection is incomplete, the residual formyl group may migrate to the lysine side chain or the amino group of the peptide backbone.

2. Reagent Introduction: In peptide synthesis, formic acid is commonly used for Boc deprotection or as a mobile phase additive in liquid chromatography. In tryptophan-containing peptide sequences, the use of formic acid to remove Boc protection leads to formylation of the indole on the tryptophan side chain, generating a byproduct (Figure 3). However, this process is reversible and can be regenerated under appropriate conditions.

Figure 3. Formylation side reaction initiated by deBoc of formic acid.

In addition, when formic acid is used as a catalyst or eluent, it may also trigger unwanted formylation side reactions under certain conditions .

3. Solvent degradation: DMF is one of the main sources of formylation and is also one of the commonly used organic solvents in peptide synthesis (now regulated).

On the one hand, DMF may degrade to produce formic acid under high temperature or strong acid and alkali conditions, thereby triggering formylation side reaction.

On the other hand, DMF can directly participate in reactions under certain conditions to form corresponding formamide derivatives. For example, in the presence of imidazole (or CDI), amino acids and their esters can react directly with DMF to obtain formamide products (Figure 4).

Figure 4. Imidazole-catalyzed formylation reaction of DMF with amino acids and their esters.

Furthermore, in the presence of peptide synthesis reagents (such as PyBroP), DMF may directly induce free carbamylation via a Vilsmeier-Haack-like reaction mechanism, terminating peptide chain elongation (Figure 5) . Similarly, in the presence of reactive acyl halide reagents such as phosphorus oxychloride, DMF may also be converted into the corresponding imineonium derivatives, promoting the formylation reaction.

Figure 5. PyBrop/DMF-induced formylation reaction

III. Diverse Pathways for N-alkylation Side Reactions

N-alkylation is a common side reaction in peptide synthesis, generally occurring on the Nα of the peptide chain ^and on the functional groups of some amino acid side chains, involving a variety of factors such as degradation of protecting groups and reagent contamination.

1. Alkylation triggered by protecting group cleavage

^{Nα -carbamate protecting groups (such as Boc, Fmoc, Z, Alloc)} in peptide chains can trigger N-alkylation side reactions. For example, in the deprotection process of Fmoc, organic bases (such as piperidine) are usually used. If the degradation byproducts are not captured and removed by the base in time, they will react with free amino groups to generate N-fluorene methylation byproducts (Figure 6).

Figure 6. Side reactions during the removal of the Fmoc protecting group.

of the allyloxycarbonyl ( Alloc ) protecting group is usually carried out using Pd(0) catalysis. If an efficient allyl scavenger is lacking in the reaction system, the newly free amino group may react with the intermediate π-allyl palladium complex to generate N-allylized byproducts (Figure 7) .

Figure 7. Allylation during the removal of the Alloc protecting group.

2. Formaldehyde-induced crosslinking and alkylation

Formaldehyde is a major contributing factor to N-alkylation side reactions in peptide synthesis, typically originating from its generation during the preparation process or from residual organic solvents. Formaldehyde can not only modify specific amino acids but also crosslink two amino acids or two functional groups within a single amino acid via methylene bridging , thus complicating the product. It is important to note that formaldehyde-mediated methylene bridging reactions require a high pH environment ; the process ceases once the pH drops below a certain threshold .

Peptide synthesis is a sophisticated and complex process, with amino group side reactions occurring throughout multiple stages, including protection, coupling, cleavage, and purification. A deep understanding of the chemical principles behind these side reactions, strict control of raw material purity, and optimization of protecting group strategies and process parameters are crucial for improving the quality and yield of peptide drugs.

Company Introduction

Suzhou Haofan Biotech Co., Ltd. (Stock Code: 301393.SZ), founded in 2003 and headquartered in Suzhou High-tech Zone, is a national high-tech enterprise providing specialty raw materials to pharmaceutical R&D and manufacturing companies worldwide. Its products are mainly used in the synthesis of peptides, nucleotides, and pharmaceuticals, covering a wide range of products including condensing agents for specialty amide bonds, protective agents, linking agents, protein cross-linking agents for antibody-drug conjugates, molecular building blocks, liposomes, and phosphorus reagents. To date, it has cumulatively developed and produced over 1,500 different products.

After more than two decades of unremitting efforts and accumulation, Haofan Biotech has continuously cultivated its expertise in the global peptide synthesis reagent field. It has now developed into a leading enterprise with extensive customized product coverage and significant advantages in large-scale production, capable of meeting the specific needs of various customers. We sincerely invite customers interested in this product to contact us to learn more about product details and explore cooperation opportunities.

References:

[1] Side Reactions in Peptide Synthesis. Yi Yang